RhumbLine Advisers’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $151K | Buy |
|
|||||
|
2024
Q4 | $167K | Sell |
|
|||||
|
2024
Q3 | $238K | Sell |
|
|||||
|
2024
Q2 | $230K | Buy |
|
|||||
|
2024
Q1 | $4.97K | Hold |
|
|||||
|
2023
Q4 | $3.01K | Hold |
|
|||||
|
2023
Q3 | $3.17K | Sell |
|
|||||
|
2023
Q2 | $8.07K | Sell |
|
|||||
|
2023
Q1 | $434K | Buy |
|
|||||
|
2022
Q4 | $1.3M | Buy |
|
|||||
|
2022
Q3 | $1.82M | Buy |
|
|||||
|
2022
Q2 | $2.1M | Buy |
|
|||||
|
2022
Q1 | $2.38M | Buy |
|
|||||
|
2021
Q4 | $5.85M | Sell |
|
|||||
|
2021
Q3 | $8.59M | Sell |
|
|||||
|
2021
Q2 | $8.46M | Sell |
|
|||||
|
2021
Q1 | $9.97M | Buy |
|
|||||
|
2020
Q4 | $8.46M | Buy |
|
|||||
|
2020
Q3 | $7.93M | Sell |
|
|||||
|
2020
Q2 | $11.3M | Buy |
|
|||||
|
2020
Q1 | $8.41M | Buy |
|
|||||
|
2019
Q4 | $9.46M | Buy |
|
|||||
|
2019
Q3 | $7.05M | Buy |
|
|||||
|
2019
Q2 | $12.1M | Sell |
|
|||||
|
2019
Q1 | $12.9M | Sell |
|
|||||
|
2018
Q4 | $13.1M | Buy |
|
|||||
|
2018
Q3 | $22.4M | Buy |
|
|||||
|
2018
Q2 | $17.9M | Buy |
|
|||||
|
2018
Q1 | $31.5M | Sell |
|
|||||
|
2017
Q4 | $22.1M | Buy |
|
|||||
|
2017
Q3 | $7.62M | Buy |
|
|||||
|
2017
Q2 | $6.04M | Buy |
|
|||||
|
2017
Q1 | $7.19M | Buy |
|
|||||
|
2016
Q4 | $2.71M | Buy |
|
|||||
|
2016
Q3 | $3.39M | Buy |
|
|||||
|
2016
Q2 | $2.65M | Buy |
|
|||||
|
2016
Q1 | $2.52M | Buy |
|
|||||
|
2015
Q4 | $3.02M | Buy |
|
|||||
|
2015
Q3 | $1.85M | Buy |
|
|||||
|
2015
Q2 | $2.06M | Sell |
|
|||||
|
2015
Q1 | $1.84M | Buy |
|
|||||
|
2014
Q4 | $2.39M | Buy |
|
|||||
|
2014
Q3 | $1.86M | Sell |
|
|||||
|
2014
Q2 | $1.98M | Buy |
|
|||||
|
2014
Q1 | $1.78M | Sell |
|
|||||
|
2013
Q4 | $1.69M | Sell |
|
|||||
|
2013
Q3 | $1.59M | Sell |
|
|||||
|
2013
Q2 | $1.77M | Buy |
|